hit

Gilead announces global remdesivir licensing plan even as patents hit rough waters in India

Gilead said it was in discussions with 'some of the world’s leading chemical and pharmaceutical manufacturing companies' to produce remdesivir for Europe, Asia and the developing world through at least 2022




hit

Letters to the editor: Take a hit




hit

Letters to the Editor: Hits & Misses




hit

KGF’s new poster looks massive, Yash starrer will hit screens on December 21




hit

Four killed as car hits truck on Yamuna Expressway